Loading clinical trials...

Cryoablation for Advanced and Refractory Desmoid Tumors | Clinical Trials | Clareo Health

UNKNOWNNCT06113094

Cryoablation for Advanced and Refractory Desmoid Tumors

Desmoid tumors, also called aggressive fibromatosis, are rare, locally invasive tumors with no potential for metastasis. The incidence is approximately 2 to 4 per million per year in the general popul...

Lead sponsor: University Hospital, Strasbourg, France•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Pierre AULOGE, MD

CONTACT

33 3 69 55 15 26 [email protected]

Related studies

COMPLETEDPhase 2

Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis

NCT01981551 · Desmoid Tumors, Aggressive Fibromatosis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 2, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment30

Start dateJul 2020

Last updatedNov 2, 2023

Condition

Desmoid Tumors

Locations shown

Service d'Imagerie Interventionnelle - CHU de Strasbourg - France

Strasbourg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions